Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

preview_player
Показать описание
Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
 
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
 
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on...
 
 
Listen to the daily Bloomberg Technology podcast here:
 
More from Bloomberg Business
Connect with us on...
Рекомендации по теме
Комментарии
Автор

Permasalahan covid 19 kedepannya masih dibutuhkan banyak AI untuk bisa menyasar dengan tepat penanganan pandemi ini agar lebih ninim resiko bagi yang terdampak maupun penularannya

Paul-exh
Автор

You might partner with Apple Watch to bring youthfulness and longevity to every user. Your AI could read blood tests! create AI to upload and analyze photos of everything eaten in 72 hours; partner with "Clean Food Living YouTube channel" or 7th Day Adventist or longevity diet (Gundry "The Longevity Paradox..."); Apple's exercise, stretching and sleep monitoring etc. Wall Street says you'll never leave home without your AI. Sanofi: Youthfulness and Longevity for EVERYONE. Thank you Sanofi.

rodneypantony
welcome to shbcf.ru